an insulin glargine injection and Sanofi's most widely prescribed insulin in the U.S. The coupon can be used at more than 70,000 retail pharmacies nationwide, GoodRx said. “Efforts to make ...

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection to treat type 1 and type 2 diabetic patients. EVA Pharma manufactures the ...

injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% ...

and neither have on this occasion gained approval for patients who are new to injectable therapy. Sanofi may have most to lose, however, as Lantus is the biggest selling standalone long-acting ...

Novo yesterday presented preliminary data which showed the formulation, O1338GT, is as effective as Sanofi’s insulin injectable Lantus in controlling blood glucose levels. But the Denmark ...